Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Talented leadership with a track record of success also is important.
"what happened to deal to produce hundreds of pounds of the biomass" Why don't you call him and find out?
Nothing will change until the shareholders that matter hold him accountable.
They should pay another promoter. Maybe get the pps down to a nickel.
The company is paying a promoter to not recommend the stock? I guess in HEPI/ZIVO world this makes sense.
Zivo signs agreement with promoter. 700k shares traded with no effect on pps. You or someone else remarked it appeared to be arranged. Promoter highlights increased volume as reason to buy the stock. I'm sure just a coincidence.
How is manipulating volume and sending a scam e-mail different than HB's activities?
I still don't understand why Zivo entered into an agreement with Redchip. You pay a company to help market your stock when you have news/developments to disseminate and want to break through the newswire clutter. Perhaps it's worthwhile to introduce your company to investors without major news if you have a CEO who knows how to make a pitch. Zivo had neither for the Redchip broadcasts.
Plenty of deals being made in the life science device field. Why isn't ZIVO able to execute a deal to generate revenue from Wellmetris? I cannot believe the shareholders that matter tolerate this incompetence.
http://www.cnbc.com/2015/08/13/google-developing-bandage-sized-glucose-monitor.html
Sell to Zoetis for .30 a share and most of us will be thrilled.
http://mobile.nytimes.com/2015/08/11/technology/jack-dorsey-twitter.html?referrer=
It'd be nice if ZIVO insiders- aside from Maggiore- bought shares.
Makes sense. That's why they've been in no hurry to generate revenue. They'll reduce administrative costs and can come back in a couple of years for an IPI one they're worth something.
Did they get dumped by Zoetis?
Onward and upward!
I asked this question when you were a Dahl sycophant- what does he do to justify his compensation package?
Almost identical to the transcript of the annual meeting presentation last year.
$3 Billion Market Cap Drug IPO
http://www.bloomberg.com/news/articles/2015-06-11/biotech-led-by-29-year-old-ceo-now-worth-billions-with-no-sales
Wouldn't it be great if Zivo had a competent management team that could pull this off? Soaring pharma stock prices and Zivo focused on a gimmick device that already caused one company to fold.
Your posts are starting to sound like those you have criticized for the past couple of years.
This is the result of no apparent new money following the Red Chip promotion. It also appears there is no near term revenue generating agreement with Zoetis. The company strategy has lacked focus.
The CEO better hope potential Wellmetris investors disregard his track record for timely monetization of a healthcare concept.
I hope everyone is taking this opportunity to selectively buy nickel shares and actively manage their position.
Why isn't management buying at these levels?
Where's the excuse for why management isn't buying at these levels.
Another promising 10-k.
Notification that annual report will be submitted late. Shocking.
I've witnessed these "quiet periods before a potential deal" since the current CEO has been there. There never is a revenue generating deal and the stock falls.
Essentially illiquid despite retaining the services of a promoter. How much is the CEO being paid not to deliver?
Broken record: "Who has spoken to Dahl of late and what does he have to say ?
Getting towards filing time and presumably an update."
Are they out of money yet? No news and practically no trading. Let's hope another Red Chip presentation isn't on the schedule.
Biotech and pharma have been hitting all time highs and this dog craters. What happens when there's a correction in the biotech/pharma sectors? Sub-penny?
http://www.politico.com/story/2015/03/apples-researchkit-wants-to-change-traditional-medical-research-115918.html?hp=c3_3
If wellmetris has any merit, it would have been picked up by a company like Apple.
Why aren't executives buying? Clearly there isn't imminent news.
I thought the arrows were green.
6 months until revenue. I've heard that for years. What happened to Wayne State and Battelle?
Wouldn't volume be above zero if there was even discussion of a buyout? There's no money to meet loan obligations; any assets that exist will go to lenders. Lenders could also be sharholders that matter. The rest will get nothing.
I'd love to hear why red chip was retained. What's the point of courting investors when you have no meaningful developments or update to your messaging strategy. I'm shocked that the shareholders who matter continue to tolerate the incompetence and pathetic pps and volume.
Longing for the days when one could only selectively buy under .30.
Burning through cash while pps sits at .07 doesn't bode well for its status as a going concern, scam or not.
Why haven't these illustrious board members or their associates bought stock? Volume and price have plummeted since they've been added to the board.